Myomo logo

MyomoNYSE American: MYO

Profile

Sector:

Healthcare

Country:

United States

IPO:

12 June 2017

Next earnings report:

07 March 2025

Last dividends:

N/A

Next dividends:

N/A
$153.95 M
-9%vs. 3y high
50%vs. sector
-vs. 3y high
-vs. sector
-6%vs. 3y high
96%vs. sector
-24%vs. 3y high
67%vs. sector

Price

after hours | Thu, 21 Nov 2024 00:30:48 GMT
$5.09+$0.06(+1.19%)

Dividend

No data over the past 3 years
$9.21 M$9.90 M
$9.21 M-$966.40 K

Analysts recommendations

Institutional Ownership

MYO Latest News

Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates
zacks.com06 November 2024 Sentiment: POSITIVE

Myomo, Inc. (MYO) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.06 per share a year ago.

Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly
businesswire.com12 September 2024 Sentiment: POSITIVE

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the official launch of the Myomo Academy, a comprehensive learning management system for professionals in Orthotics & Prosthetics (O&P) and Rehabilitation. The Myomo Academy is being launched during the 2024 AOPA (American Orthotic and Prosthe.

Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024
businesswire.com05 June 2024 Sentiment: POSITIVE

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, chairman and chief executive officer and David Henry, chief financial officer, will present and host one-on-one meetings with investors at the Sidoti Virtual Investor conference being held on June 12-13, 2024. Management's presentat.

Myomo to Report First Quarter Financial Results on May 8, 2024
Business Wire01 May 2024 Sentiment: NEGATIVE

Myomo, Inc. will release its financial results for the first quarter of 2024 on May 8, 2024, and will hold a conference call at 4:30 p.m. ET that same day with remarks by chairman and chief executive Paul R. Gudonis.

Myomo, Inc.: In Motion To Accelerating Revenue Growth
Seeking Alpha10 March 2024 Sentiment: POSITIVE

Medicare decision created a multi-decade revenue growth opportunity. Soft Q1 guidance due to non-recurring timing issues. 2024 guidance gives only partial-year credit to reimbursement change.

Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research07 March 2024 Sentiment: NEGATIVE

Myomo, Inc. (MYO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.29 per share a year ago.

What Makes Myomo, Inc. (MYO) a Good Fit for 'Trend Investing'
Zacks Investment Research20 December 2023 Sentiment: POSITIVE

If you are looking for stocks that are well positioned to maintain their recent uptrend, Myomo, Inc. (MYO) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Myomo: Market Severely Undervaluing Opportunity
Seeking Alpha01 December 2023 Sentiment: POSITIVE

Market undervalues MYO stock due to poor understanding of CMS process. MYO is able to generate revenues in excess of $100mm/yr. MYO valuation gap will close before February 2024, when the final CMS price is published.

Myomo, Inc. (MYO) Q3 2023 Earnings Call Transcript
Seeking Alpha07 November 2023 Sentiment: POSITIVE

Myomo, Inc. (MYO) Q3 2023 Earnings Call Transcript

Why Is Myomo (MYO) Stock Down 13% Today?
InvestorPlace28 August 2023 Sentiment: NEGATIVE

Myomo (NYSEMKT: MYO ) stock is dropping on Monday after the wearable medical robotics company priced a public share offering. A press release from Myomo highlights details of its planned public offering.

What type of business is Myomo?

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

What sector is Myomo in?

Myomo is in the Healthcare sector

What industry is Myomo in?

Myomo is in the Medical Devices industry

What country is Myomo from?

Myomo is headquartered in United States

When did Myomo go public?

Myomo initial public offering (IPO) was on 12 June 2017

What is Myomo website?

https://myomo.com

Is Myomo in the S&P 500?

No, Myomo is not included in the S&P 500 index

Is Myomo in the NASDAQ 100?

No, Myomo is not included in the NASDAQ 100 index

Is Myomo in the Dow Jones?

No, Myomo is not included in the Dow Jones index

When was Myomo the previous earnings report?

No data

When does Myomo earnings report?

The next expected earnings date for Myomo is 07 March 2025